166 related articles for article (PubMed ID: 23153913)
1. Selective factor XIIa inhibition attenuates silent brain ischemia: application of molecular imaging targeting coagulation pathway.
Chen JW; Figueiredo JL; Wojtkiewicz GR; Siegel C; Iwamoto Y; Kim DE; Nolte MW; Dickneite G; Weissleder R; Nahrendorf M
JACC Cardiovasc Imaging; 2012 Nov; 5(11):1127-38. PubMed ID: 23153913
[TBL] [Abstract][Full Text] [Related]
2. Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding.
Hagedorn I; Schmidbauer S; Pleines I; Kleinschnitz C; Kronthaler U; Stoll G; Dickneite G; Nieswandt B
Circulation; 2010 Apr; 121(13):1510-7. PubMed ID: 20308613
[TBL] [Abstract][Full Text] [Related]
3. The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.
Krupka J; May F; Weimer T; Pragst I; Kleinschnitz C; Stoll G; Panousis C; Dickneite G; Nolte MW
PLoS One; 2016; 11(1):e0146783. PubMed ID: 26815580
[TBL] [Abstract][Full Text] [Related]
4. Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit.
Xu Y; Cai TQ; Castriota G; Zhou Y; Hoos L; Jochnowitz N; Loewrigkeit C; Cook JA; Wickham A; Metzger JM; Ogletree ML; Seiffert DA; Chen Z
Thromb Haemost; 2014 Apr; 111(4):694-704. PubMed ID: 24336918
[TBL] [Abstract][Full Text] [Related]
5. FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.
May F; Krupka J; Fries M; Thielmann I; Pragst I; Weimer T; Panousis C; Nieswandt B; Stoll G; Dickneite G; Schulte S; Nolte MW
Br J Haematol; 2016 Jun; 173(5):769-78. PubMed ID: 27018425
[TBL] [Abstract][Full Text] [Related]
6. Factor XIIa as a Novel Target for Thrombosis: Target Engagement Requirement and Efficacy in a Rabbit Model of Microembolic Signals.
Barbieri CM; Wang X; Wu W; Zhou X; Ogawa AM; O'Neill K; Chu D; Castriota G; Seiffert DA; Gutstein DE; Chen Z
J Pharmacol Exp Ther; 2017 Mar; 360(3):466-475. PubMed ID: 28035006
[TBL] [Abstract][Full Text] [Related]
7. Targeting coagulation factor XII as a novel therapeutic option in brain trauma.
Hopp S; Albert-Weissenberger C; Mencl S; Bieber M; Schuhmann MK; Stetter C; Nieswandt B; Schmidt PM; Monoranu CM; Alafuzoff I; Marklund N; Nolte MW; Sirén AL; Kleinschnitz C
Ann Neurol; 2016 Jun; 79(6):970-82. PubMed ID: 27043916
[TBL] [Abstract][Full Text] [Related]
8. New Infestin-4 Mutants with Increased Selectivity against Factor XIIa.
Kolyadko VN; Lushchekina SV; Vuimo TA; Surov SS; Ovsepyan RA; Korneeva VA; Vorobiev II; Orlova NA; Minakhin L; Kuznedelov K; Severinov KV; Ataullakhanov FI; Panteleev MA
PLoS One; 2015; 10(12):e0144940. PubMed ID: 26670620
[TBL] [Abstract][Full Text] [Related]
9. Dimiconin, a novel coagulation inhibitor from the kissing bug, Triatoma dimidiata, a vector of Chagas disease.
Ishimaru Y; Gomez EA; Zhang F; Martini-Robles L; Iwata H; Sakurai T; Katakura K; Hashiguchi Y; Kato H
J Exp Biol; 2012 Oct; 215(Pt 20):3597-602. PubMed ID: 22771751
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a novel factor XIIa inhibitor in the hematophagous insect, Triatoma infestans (Hemiptera: Reduviidae).
Campos IT; Tanaka-Azevedo AM; Tanaka AS
FEBS Lett; 2004 Nov; 577(3):512-6. PubMed ID: 15556638
[TBL] [Abstract][Full Text] [Related]
11. Novel family of insect salivary inhibitors blocks contact pathway activation by binding to polyphosphate, heparin, and dextran sulfate.
Alvarenga PH; Xu X; Oliveira F; Chagas AC; Nascimento CR; Francischetti IM; Juliano MA; Juliano L; Scharfstein J; Valenzuela JG; Ribeiro JM; Andersen JF
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2759-70. PubMed ID: 24092749
[TBL] [Abstract][Full Text] [Related]
12. Cerebral tomographic findings in patients undergoing carotid endarterectomy for asymptomatic carotid stenosis: short-term and long-term implications.
Cao P; Zannetti S; Giordano G; De Rango P; Parlani G; Caputo N
J Vasc Surg; 1999 Jun; 29(6):995-1005. PubMed ID: 10359933
[TBL] [Abstract][Full Text] [Related]
13. PET Detection of Cerebral Necrosis Using an Infarct-Avid Agent 2-Deoxy-2-[
Houson H; Mdzinarishvili A; Gali H; Sidorov E; Awasthi V
Mol Imaging Biol; 2020 Oct; 22(5):1353-1361. PubMed ID: 32557188
[TBL] [Abstract][Full Text] [Related]
14. The full-length cDNA of anticoagulant protein infestin revealed a novel releasable Kazal domain, a neutrophil elastase inhibitor lacking anticoagulant activity.
Lovato DV; Nicolau de Campos IT; Amino R; Tanaka AS
Biochimie; 2006 Jun; 88(6):673-81. PubMed ID: 16469426
[TBL] [Abstract][Full Text] [Related]
15. Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Weber R; Weimar C; Wanke I; Möller-Hartmann C; Gizewski ER; Blatchford J; Hermansson K; Demchuk AM; Forsting M; Sacco RL; Saver JL; Warach S; Diener HC; Diehl A;
Stroke; 2012 Feb; 43(2):350-5. PubMed ID: 22267825
[TBL] [Abstract][Full Text] [Related]
16. A Synthetic Factor XIIa Inhibitor Blocks Selectively Intrinsic Coagulation Initiation.
Baeriswyl V; Calzavarini S; Chen S; Zorzi A; Bologna L; Angelillo-Scherrer A; Heinis C
ACS Chem Biol; 2015 Aug; 10(8):1861-70. PubMed ID: 25989088
[TBL] [Abstract][Full Text] [Related]
17. The Kazal-type inhibitors infestins 1 and 4 differ in specificity but are similar in three-dimensional structure.
Campos IT; Souza TA; Torquato RJ; De Marco R; Tanaka-Azevedo AM; Tanaka AS; Barbosa JA
Acta Crystallogr D Biol Crystallogr; 2012 Jun; 68(Pt 6):695-702. PubMed ID: 22683792
[TBL] [Abstract][Full Text] [Related]
18. Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs.
Wilbs J; Kong XD; Middendorp SJ; Prince R; Cooke A; Demarest CT; Abdelhafez MM; Roberts K; Umei N; Gonschorek P; Lamers C; Deyle K; Rieben R; Cook KE; Angelillo-Scherrer A; Heinis C
Nat Commun; 2020 Aug; 11(1):3890. PubMed ID: 32753636
[TBL] [Abstract][Full Text] [Related]
19. Multiple Silent Brain Infarcts Are Associated with Severer Stroke in Patients with First-Ever Ischemic Stroke without Advanced Leukoaraiosis.
Chen DW; Wang YX; Shi J; Zhang WQ; Yang F; Yin YW; Ma LN
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1988-1995. PubMed ID: 28688715
[TBL] [Abstract][Full Text] [Related]
20. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
Hasegawa Y; Yamaguchi T; Omae T; Woodward M; Chalmers J;
Hypertens Res; 2004 Mar; 27(3):147-56. PubMed ID: 15080373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
